AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · Real-Time Price · USD
3.270
-0.180 (-5.22%)
At close: Apr 2, 2026, 4:00 PM EDT
3.150
-0.120 (-3.67%)
After-hours: Apr 2, 2026, 6:53 PM EDT
AN2 Therapeutics Market Cap
AN2 Therapeutics has a market cap or net worth of $117.53 million as of April 2, 2026. Its market cap has increased by 169.42% in one year.
Market Cap
117.53M
Enterprise Value
59.53M
1-Year Change
169.42%
Ranking
Category
Stock Price
$3.27
Market Cap Chart
Since the IPO on March 25, 2022, AN2 Therapeutics's market cap has decreased from $281.10M to $117.53M, a decrease of -58.19%. That is a compound annual growth rate of -19.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 117.53M | 276.23% |
| Dec 31, 2025 | 31.24M | -24.24% |
| Dec 31, 2024 | 41.23M | -93.23% |
| Dec 29, 2023 | 609.40M | 229.57% |
| Dec 30, 2022 | 184.91M | -34.22% |
| Mar 25, 2022 | 281.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alpha Cognition | 130.02M |
| Agenus | 127.87M |
| Innate Pharma | 125.73M |
| Equillium | 124.56M |
| Sangamo Therapeutics | 124.32M |
| PepGen | 119.57M |
| Genelux | 114.04M |
| ProMIS Neurosciences | 112.19M |